BD (Becton, Dickinson and Company), a leading global medical technology company, has announced that following the approval of the BD Saf-T-Intima™ Safety Integrated IV Catheter System for use in subcutaneous infusion therapies that it will be collaborating with pain management and palliative care infusion pump specialists, CME Medical, to increase coverage in the UK and Ireland and to provide expanded specialist support to its growing Saf-T-Intima™ customer base.
Jonathan Hughes, UK Marketing Manager for BD explains, “BD Saf-T-Intima™, for use in subcutaneous infusion therapies such as rehydration and palliative care, is growing in popularity due to an increasing number of healthcare professionals who are looking for ways to increase patient comfort and in-dwell times while enabling cost savings and reducing the risk of sharps injuries and infection.
With palliative care being a key therapy area for subcutaneous infusion, it was a logical step for BD to collaborate with CME Medical which already has a large and clinically respected presence within Acute and Community Care following the popularity and wide adoption of CME Medical’s T34TM Ambulatory Syringe Pumps.”
